Almost half of teenagers with obesity taking the popular drug semaglutide (Ozempic, Wegovy) lost enough weight to move to an overweight or healthy BMI category.
July 10, 2023 – Almost half of teenagers with obesity taking the popular drug semaglutide lost enough weight over almost a year a half to move to an overweight or healthy body mass index, or BMI, category.
Compared to just 12% of 67 teenagers receiving a placebo or dummy shot, 45% of 133 adolescents taking semaglutide changed BMI groups in a study. The shots were given once a week under the skin.Obesity is defined, for example, as a BMI of 30 kg/mis their height in meters, squared. Teenagers in this BMI class taking Wegovy or Ozempic were 23 times more likely to end up with a BMI of 25 to 29.9 kg/mThe researchers called semaglutide “highly effective” for changing BMI status in teenagers.
As impressive as the results were, Aaron S. Kelly, PhD, of the Department of Pediatrics and Center for Pediatric Obesity Medicine at the University of Minnesota, and colleagues emphasized that exercise and lifestyle changes are required along with anti-obesity medication to get the best results. The research was not designed to specifically look at health benefits. But the researchers found teenagers who moved at least two BMI categories had more improvements in cholesterol, blood pressure, and weight circumference , for example, compared to others.. Kelly and colleagues wrote that their study supports starting anti-obesity medications earlier to help teenagers with obesity.from the American Academy of Pediatrics.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Popular weight loss drug gets new warningWegovy and Ozempic are brand names for a drug called semaglutide.
続きを読む »
EU probes Ozempic, weight-loss drug Saxenda after reports of suicidal thoughtsThe European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.
続きを読む »
EU Investigates Ozempic Maker After Reports Of Suicidal ThoughtsThe Danish pharma giant finds itself under scrutiny once again- this time, from European regulators.
続きを読む »
Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal ThoughtsEuropean drug regulators are reviewing the risk of thoughts of suicide and self-harm in people taking Ozempic and another weight-loss drug after getting three reports
続きを読む »
Jodie Whittaker's Doctor Who Era Almost Brought Back 1 Classic Villain: 'Which Is A Shame'Jodie Whittaker's Doctor Who era almost brought back one classic villain in season 12, as writer Pete McTighe called the missed opportunity 'a shame.'
続きを読む »
Michelle Pfeiffer almost played Carmy's mom on The BearMelanie Griffith was also in the running to play Donna Berzatto in the show's guest-star heavy 'Fishes'
続きを読む »